PFE
Pfizer Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders -10.0% ·
aandelenstroom -6.9% ·
netto nieuwe posities -11.1%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +3 | 3.07B | $73.90B | +7 | −3 |
| Q1 2026 | 174 | -2 | 3.01B | $84.42B | +3 | −6 |
| Q4 2025 | 175 | 0 | 3.18B | $79.18B | +2 | −1 |
| Q3 2025 | 25 | -1 | 1.84B | $46.80B | +1 | −3 |
| Q2 2025 | 24 | -1 | 1.79B | $43.32B | — | −1 |
| Q1 2025 | 22 | +1 | 777.51M | $19.69B | +2 | −1 |
| Q4 2024 | 21 | +2 | 779.18M | $20.66B | +2 | — |
| Q3 2024 | 18 | -2 | 507.62M | $14.68B | — | −2 |
| Q2 2024 | 20 | — | 545.09M | $15.24B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 163.73M | -1.6% | $4.74B | 0.8% | ▼ Trim | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passief) | 117.67M | +1.6% | $3.39B | 0.3% | ▲ Add | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passief) | 117.67M | +1.6% | $3.39B | 0.3% | ▲ Add | 2 | SEC ↗ |
| 12 | Norges Bank ✦ (passief) | 88.35M | +5.2% | $2.56B | 0.4% | ▲ Add | 2 | SEC ↗ |
| 13 | Capital World Investors ✦ | 53.69M | -39.1% | $1.55B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 20.96M | +22.6% | $606.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 20.96M | +22.6% | $606.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | Millennium Management ✦ | 15.47M | -22.3% | $447.80M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 17 | Marshall Wace ✦ | 14.73M | +173.9% | $426.29M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 18 | Marshall Wace ✦ | 14.73M | +173.9% | $426.29M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 14.73M | +173.9% | $426.29M | 0.6% | ▲ Add | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 8.60M | -1.2% | $248.94M | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 8.06M | -60.5% | $233.32M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 8.06M | -60.5% | $233.32M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 6.21M | +226.7% | $179.71M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 5.52M | -34.5% | $159.77M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 5.52M | -34.5% | $159.77M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 1.68M | +173.8% | $48.53M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 1.68M | +173.8% | $48.53M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 1.68M | +173.8% | $48.53M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 1.68M | +173.8% | $48.53M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 1.66M | -6.9% | $48.05M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 31 | GAMCO Investors ✦ | 677.74K | +16.7% | $19.61M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 32 | Fairfax Financial ✦ | 460.90K | 0.0% | $13.33M | 1.2% | Held | 2 | SEC ↗ |
| 33 | Dodge & Cox ✦ | 112.78K | -2.7% | $3.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 34 | Gotham Asset Management ✦ | 32.55K | +27.8% | $941,881 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Bridgewater Associates ✦ | 11.85K | -66.6% | $342,852 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Renaissance Technologies | $131.51M | was 0.2% |
| Point72 Asset Management | $19.93M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 225.90K aandelen, $6,343 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Officer, Director · Chairman & CEO · 38.00K aand @ 26.34 · $1.00M
Open-market verkopen (S)
Geen open-market insider-verkopen in ons dekkingsvenster.
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie